Words by Jade Williams
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering recent collaborations, drug approvals and much more
08 June
Gilead Sciences and Westminster Drug Project repartner to eliminate hepatitis C in drug and alcohol services by end of 2023
14 June
Merck and the Mulliken Centre enter three-year collaboration for machine learning project
20 June
University of Manchester researchers discover blood vessel link to halt Alzheimer’s progression
23 June
Novartis renews Kigali Declaration commitment, investing $250m over five years for neglected tropical diseases
30 June
Pfizer announces commitment to reach Net-Zero Standard ahead of schedule by 2040
05 July
Juvisé Pharmaceuticals completes €400m refinancing after acquiring rights to antimicrobial Pylera
12 July
ABPI sets new NHS data usage regulations for pharma companies
18 July
Long-awaited Haleon demerger completed by GSK
25 July
EC extends Bavarian Nordic’s Imvanex smallpox vaccine license to tackle monkeypox
28 July
GSK signs agreement to supply pandemic influenza vaccine Adjupanrix to 12 European countries
02 Aug
CSL Limited receives regulatory clearances to acquire Vifor Pharma, with Hervé Gisserot appointed as General Manager
04 Aug
Sanofi and Innovent Biologics collaborate to accelerate development of oncology medicines and expand presence in China
This article features in GOLD 23 – read the full issue here.